Regeneron Pharmaceuticals (REGN) Stock: Revenue, Earnings, Margins & Valuation
Regeneron Pharmaceuticals share price
| Price (USD) | 927.89 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 93.84 USD bn |
Annual and quarterly filings: SEC EDGAR – Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (REGN), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report, visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Regeneron Pharmaceuticals business model
The income statement of Regeneron Pharmaceuticals is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
Sector: Health Care
More stock analyses like Regeneron Pharmaceuticals
- ResMed stock (RMD)
- Revvity stock (RVTY)
- Solventum stock (SOLV)
- Steris stock (STE)
- Regions Financial Corporation stock (RF)
- Regency Centers stock (REG)
- Republic Services stock (RSG)
- Reddit stock (RDDT)